Glucosamine sulfate and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data

Summary:

Paranasal sinus hypersecretion is reported only by a few people who take Glucosamine Sulfate.

The phase IV clinical study analyzes which people take Glucosamine sulfate and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 1,576 people who have side effects while taking Glucosamine sulfate from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 01, 2022

1,576 people reported to have side effects when taking Glucosamine sulfate.
Among them, 3 people (0.19%) have Paranasal sinus hypersecretion.


What is Glucosamine sulfate?

Glucosamine sulfate has active ingredients of glucosamine sulfate. It is often used in joint pain. eHealthMe is studying from 1,680 Glucosamine sulfate users for its effectiveness, alternative drugs and more.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 729 drugs and 393 conditions by eHealthMe.

Number of Glucosamine sulfate and Paranasal sinus hypersecretion reports submitted per year:

Could Glucosamine sulfate cause Paranasal sinus hypersecretion?

Gender of people who have Paranasal sinus hypersecretion when taking Glucosamine sulfate *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Paranasal sinus hypersecretion when taking Glucosamine sulfate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Glucosamine sulfate *:

  1. Prolia: 2 people, 66.67%
  2. Aspirin: 2 people, 66.67%
  3. Vitamin D: 1 person, 33.33%
  4. Valacyclovir: 1 person, 33.33%
  5. Imbruvica: 1 person, 33.33%
  6. Fish Oil: 1 person, 33.33%
  7. Centrum Silver: 1 person, 33.33%
  8. Calcium Citrate: 1 person, 33.33%
  9. Baby Aspirin: 1 person, 33.33%

Common side effects people have besides Paranasal sinus hypersecretion *:

  1. Ear Congestion: 2 people, 66.67%
  2. Ingrowing Nail: 2 people, 66.67%
  3. Upper Respiratory Tract Infection: 2 people, 66.67%
  4. Toothaches (tooth pain): 2 people, 66.67%
  5. Tendon Pain: 2 people, 66.67%
  6. Pain In Jaw: 2 people, 66.67%
  7. Pain In Extremity: 2 people, 66.67%
  8. Ear Pain: 2 people, 66.67%
  9. Onychalgia (nail biting): 2 people, 66.67%
  10. Muscle Aches (muscle pain): 2 people, 66.67%

Common conditions people have *:

  1. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 66.67%
  2. Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 66.67%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine sulfate and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Paranasal sinus hypersecretion and when was it recovered:

Expand to all the drugs that have ingredients of glucosamine sulfate:

Alternative drugs to, pros and cons of Glucosamine sulfate:

Common Glucosamine sulfate side effects:

Browse all side effects of Glucosamine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Paranasal sinus hypersecretion treatments and more:

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

All the drugs that are associated with Paranasal sinus hypersecretion:

Common conditions associated with Paranasal sinus hypersecretion:

All the conditions that are associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study uses data from the FDA. It is based on glucosamine sulfate (the active ingredients of Glucosamine sulfate) and Glucosamine sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: